AKBA FY 2019 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$335M+61.3% YoY

Gross Profit

$190M56.6% margin

Operating Income

-$286M-85.5% margin

Net Income

-$280M-83.5% margin

EPS (Diluted)

$-2.36

Cash Flow

Operating Cash Flow

-$257M

Free Cash Flow

-$264M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$771M

Total Liabilities

$376M

Stockholders' Equity

$395M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$335M	$208M	+61.3%
Gross Profit	$190M	$200M	-5.2%
Operating Income	-$286M	-$178M	-60.7%
Net Income	-$280M	-$172M	-62.7%